A detailed history of Coastline Trust CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Coastline Trust CO holds 8,320 shares of AZN stock, worth $594,214. This represents 0.08% of its overall portfolio holdings.

Number of Shares
8,320
Previous 8,320 -0.0%
Holding current value
$594,214
Previous $563,000 15.1%
% of portfolio
0.08%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

SELL
$61.89 - $69.28 $27,231 - $30,483
-440 Reduced 5.02%
8,320 $560,000
Q3 2023

Oct 17, 2023

SELL
$64.85 - $71.7 $63,877 - $70,624
-985 Reduced 10.11%
8,760 $593,000
Q3 2022

Nov 03, 2022

SELL
$53.02 - $135.75 $4,718 - $12,081
-89 Reduced 0.91%
9,745 $534,000
Q2 2022

Jul 22, 2022

SELL
$59.26 - $71.14 $3,851 - $4,624
-65 Reduced 0.66%
9,834 $650,000
Q1 2022

May 04, 2022

BUY
$55.72 - $67.12 $4,959 - $5,973
89 Added 0.91%
9,899 $657,000
Q4 2021

Feb 10, 2022

BUY
$54.02 - $63.83 $4,645 - $5,489
86 Added 0.88%
9,810 $571,000
Q3 2021

Nov 09, 2021

SELL
$55.56 - $60.79 $11,667 - $12,765
-210 Reduced 2.11%
9,724 $584,000
Q2 2021

Aug 10, 2021

BUY
$48.42 - $60.18 $2,421 - $3,009
50 Added 0.51%
9,934 $595,000
Q1 2021

May 10, 2021

BUY
$47.16 - $54.44 $11,554 - $13,337
245 Added 2.54%
9,884 $491,000
Q4 2020

Feb 12, 2021

BUY
$48.52 - $58.02 $127,122 - $152,012
2,620 Added 37.33%
9,639 $482,000
Q3 2020

Oct 15, 2020

BUY
$53.07 - $61.1 $73,714 - $84,867
1,389 Added 24.67%
7,019 $385,000
Q1 2020

Jun 10, 2020

SELL
$37.79 - $51.33 $6,424 - $8,726
-170 Reduced 2.93%
5,630 $251,000
Q3 2019

Oct 18, 2019

SELL
$40.12 - $45.47 $24,673 - $27,964
-615 Reduced 9.59%
5,800 $259,000
Q2 2019

Jul 18, 2019

BUY
$37.28 - $41.68 $49,955 - $55,851
1,340 Added 26.4%
6,415 $265,000
Q1 2019

Apr 25, 2019

BUY
$35.49 - $43.02 $180,111 - $218,326
5,075 New
5,075 $205,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $221B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.